HWHollis J. Weidenbacher

Hollis J. Weidenbacher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hollis J. Weidenbacher has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Family-involved interventions may offer unique benefits for Veterans with posttraumatic stress disorder (PTSD) experiencing high family strain.

    by Megan Shepherd-Banigan, Hope Salameh, Abigail Shapiro, Karen M. Stechuchak, Stephanie Y. Wells, Joseph H. Neiman, Hollis J. Weidenbacher, Madeleine R. Eldridge, Tiera J. Lanford-Davey, Barbara Bokhour, et al.

    Family strain, which reflects the overall function of the family system, could play an important role in routine posttraumatic stress disorder (PTSD) care. We examined how high/low family strain influences perceptions of a family-involved intervention for Veterans with PTSD to inform the design and implementation of family-centered interventions in routine PTSD care. Sequential explanatory mixed methods study that analyzed qualitative exit interview data from a three-session family-involved pilot study stratified by Veteran baseline scores of family strain (Veteran n = 16; support partner [SP] n = 12). Themes were identified via rapid qualitative analysis of interview data categorized by high/low strain. Eleven Veterans (nine associated SPs) were classified as experiencing high and five Veterans (three associated SPs) were classified as experiencing low family strain. While nearly 50% of Veterans reported belonging to a non-White racial group, all of the Veterans were men. Themes reflected preintervention expectations, intervention experiences, and postintervention changes. Differences in intervention experiences were observed with different family strain levels. Participants in the high strain group articulated concrete goals for the intervention and provided more details about benefits, including an enhanced understanding of PTSD, improved family communication, and increased social support. Participants in the high strain group reported more discomfort with the intervention process, especially the conjoint sessions. Family-involved interventions for Veterans with high family strain are feasible and may have even greater benefits than for Veterans reporting low family strain. Future research is needed to empirically test this hypothesis and to understand the experiences of female Veterans. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

  • Prevalence of Toxic Exposures Among Women Veterans With Breast or Gynecologic Cancers Receiving Veterans Affairs (VA) Care

    by Megan Shepherd-Banigan, Graham L Cummin, Theodore S Berkowitz, Hollis J Weidenbacher, Haley Moss, Neetu Chawla, Karen M Goldstein, Aditi Hazra, Erin M Bayley, Sarah Colonna, et al.

    Introduction: Toxic exposures have been linked to hormonal disruption and DNA damage, increasing risk for hormone-sensitive cancers, such as breast and gynecologic cancers. However, the effect of toxic exposure on women Veteran cancer risk is unknown, especially for Veterans who served in the recent Middle East conflict because of the latency with which cancer develops. This study assesses the prevalence of toxic exposures among women Veterans with diagnosed breast and gynecologic cancers. Materials and Methods: This descriptive, cross-sectional study examines self-reported toxic exposures among Veterans diagnosed with breast or gynecologic cancers in the Veterans Health Administration and who participated in a clinical care survey with a nurse navigator. Data were obtained from Veteran Health Affairs (VA) electronic medical records and data from the Breast and Gynecologic Oncology System of Excellence (BGSoE) Program Dashboard. Exposure categories include air pollutants, occupational hazards, chemicals, physical agents, and biological risks. We compared demographic, health, and geographic factors between Veterans who reported hazardous exposure versus those who did not and described the characteristics of those hazards. Results: Nearly 50% of women Veterans in the sample reported experiencing a hazardous exposure during military service. Over 80% reported feeling very or somewhat concerned about the exposure. Airborne exposures were the most frequently reported. Conclusions: Women Veterans with breast and/or gynecologic cancer frequently report hazardous exposures during military service, which may impact their actual and perceived cancer risk and subsequent health care utilization. Future research is needed to assess the relationship between perceived/reported and actual hazardous exposures and inform any needed cancer interception.


  • Feasibility of a family-involved intervention to increase engagement in evidenced-based psychotherapies for posttraumatic stress disorder: A pilot study.

    by Megan Shepherd-Banigan, Abigail Shapiro, Karen M. Stechuchak, Shirley Glynn, Patrick Calhoun, Princess E. Ackland, Barbara Bokhour, David Edelman, Margaret Falkovic, Hollis J. Weidenbacher, et al.

    To assess the feasibility of a family-involved intervention, family support in mental health recovery (FAMILIAR), for veterans with posttraumatic stress disorder (PTSD) seeking psychotherapy at a single Veterans Administration Health System. This mixed-methods study reports qualitative and quantitative findings from a single-group pilot of 24 veterans and their support partners (SPs) about experiences with the intervention and interviews with eight VA mental health clinicians and leaders and the study interventionist to explore intervention feasibility. Findings across data sources were merged within domains of Bowen and colleagues' pilot study feasibility framework. Out of 24 dyads, 16 veterans and 15 associated SPs completed the intervention. Participants viewed the intervention to be valuable and feasible. Veterans and SPs reported that they enrolled in the study to develop a shared understanding of PTSD and treatment. While participants identified few logistical barriers, finding a time for conjoint sessions could be a challenge. Veterans, SPs, and providers discussed benefits of the intervention, including that it facilitated conversation between the veteran and SP about PTSD and mental health care and helped to prepare the dyad for treatment. Providers noted potential challenges integrating family-involved interventions into clinical workflow in VA and suggested the need for additional training and standardized procedures for family-centered care. Our study identified potential implementation facilitators (e.g., standard operating procedures about session documentation, confidentiality, and family ethics) and challenges (e.g., clinical workflow integration) that require further study to bring FAMILIAR into routine clinical care. (PsycInfo Database Record (c) 2024 APA, all rights reserved).


  • Open Access

    Improving Cancer Care for Women Seeking Services in the Veterans Health Administration Through the Breast and Gynecological Oncology System of Excellence

    by Megan Shepherd-Banigan, Leah L Zullig, Theodore S Z Berkowitz, Graham Cummin, Karen M Goldstein, Michael J Kelley, Neetu Chawla, Hollis J Weidenbacher, Aditi Hazra, Ahmad S Halwani, et al.

    Women are the fastest growing population among Veterans and have substantial risk factors that increase their likelihood for developing cancer. To ensure that the Department of Veterans Affairs Veterans Health Administration (VHA) offers the best possible cancer care to women Veterans, it established the Breast and Gynecologic Oncology System of Excellence (BGSoE) in 2021. The BGSoE offers telehealth oncology services and a comprehensive cancer navigation program. Veterans are identified through physician referral or through the BGSoE dashboard which integrates ICD-10 codes and text mining from VA electronic health records to identify eligible Veterans with breast or gynecological cancers. Descriptive statistics, including Veteran demographics and geographical location, were derived from BGSoE dashboard data. From January 1, 2021 to March 15, 2024, the BGSoE identified a total of 7,187 incident cases of breast or gynecological cancer among living Veterans. Most cancers were breast (78%) versus gynecological cancers (22%) and 10% of Veterans with breast cancer were identified as male. The average age at diagnosis was 59 for Veterans with breast cancer and 56 for those Veterans with gynecological cancers. Among Veterans in the BGSoE, 28% identified as Black and 6% identified as Hispanic. As the prevalence of women Veterans requiring cancer-related care continues to rise, it will be essential for VHA to evaluate the equitable reach, quality, and acceptability of women-focused cancer health services. The BGSoE focuses on providing high-quality and coordinated clinical cancer care. Veterans Health Administration also established the Center for Oncology Outcomes Review and Gender (COURAGE) to evaluate the BGSoE and continue to strengthen cancer care services in VHA. Initial evaluation objectives include establishing an evidence base regarding Veterans with breast and gynecological cancers, including their experiences with cancer care in the VHA. Eventually, COURAGE will provide ongoing monitoring and evaluation to continue to grow and improve cancer care in the VHA.


  • Open Access

    Exploring the importance of predisposing, enabling, and need factors for promoting Veteran engagement in mental health therapy for post-traumatic stress: a multiple methods study

    by Megan Shepherd-Banigan, Abigail Shapiro, Karen M. Stechuchak, Kate L. Sheahan, Princess E. Ackland, Valerie A. Smith, Barbara G. Bokhour, Shirley M. Glynn, Patrick S. Calhoun, David Edelman, et al.

    Purpose: This study explored Veteran and family member perspectives on factors that drive post-traumatic stress disorder (PTSD) therapy engagement within constructs of the Andersen model of behavioral health service utilization. Despite efforts by the Department of Veterans Affairs (VA) to increase mental health care access, the proportion of Veterans with PTSD who engage in PTSD therapy remains low. Support for therapy from family members and friends could improve Veteran therapy use. Methods: We applied a multiple methods approach using data from VA administrative data and semi-structured individual interviews with Veterans and their support partners who applied to the VA Caregiver Support Program. We integrated findings from a machine learning analysis of quantitative data with findings from a qualitative analysis of the semi-structured interviews. Results: In quantitative models, Veteran medical need for health care use most influenced treatment initiation and retention. However, qualitative data suggested mental health symptoms combined with positive Veteran and support partner treatment attitudes motivated treatment engagement. Veterans indicated their motivation to seek treatment increased when family members perceived treatment to be of high value. Veterans who experienced poor continuity of VA care, group, and virtual treatment modalities expressed less care satisfaction. Prior marital therapy use emerged as a potentially new facilitator of PTSD treatment engagement that warrants more exploration. Conclusions: Our multiple methods findings represent Veteran and support partner perspectives and show that amid Veteran and organizational barriers to care, attitudes and support of family members and friends still matter. Family-oriented services and intervention could be a gateway to increase Veteran PTSD therapy engagement.


  • Open Access

    Geographic Variation in Obesity, Behavioral Treatment, and Bariatric Surgery for Veterans

    by Matthew L. Maciejewski, David E. Arterburn, Theodore S.Z. Berkowitz, Hollis J. Weidenbacher, Chuan‐Fen Liu, Maren K. Olsen, Luke M. Funk, James E. Mitchell, Valerie A. Smith

    Objective: This study aims to describe geographic variation in veterans’ prevalence of obesity, participation in Veterans Health Administration’s behavioral weight management program (MOVE!), and receipt of bariatric surgery in fiscal year (FY) 2016.Methods: In this retrospective cohort study of veterans with obesity who received Veterans Health Administration care in FY2016, electronic health record data were obtained on weight, height, outpatient visits to the MOVE! program, and bariatric surgeries. For each Veterans Integrated Service Network (VISN) region, the prevalence rate of veterans with obesity (BMI ≥ 30 kg/m2), MOVE! participation rates, and bariatric surgery rates are presented.Results: The prevalence of obesity in veterans ranged from 30.5% to 40.5% across VISNs in FY2016. MOVE! participation among veterans with obesity was low (2.8%‐6.9%) across all VISNs, but veterans with class II and III obesity (BMI ≥ 35) had higher MOVE! participation rates (4.3%‐10.8%) than veterans with class I obesity. There was 20‐fold variation across VISNs in receipt of bariatric surgery among veterans with BMI ≥ 35, ranging from 0.01% to 0.2%. Among veterans with BMI ≥ 35 participating in MOVE!, there was 46‐fold variation in bariatric surgery provision, ranging from 0.07% to 3.27%.Conclusions: Despite veterans’ high prevalence of obesity, behavioral and surgical weight management participation is low and varies across regions.


  • Open Access

    Demand for Weight Loss Counseling After Copayment Elimination

    by Matthew L. Maciejewski, William S. Yancy, Maren Olsen, Hollis J. Weidenbacher, David Abbott, Morris Weinberger, Santanu Datta, Leila C. Kahwati

    Overweight and obesity are public health issues in the United States, and veterans have a higher rate of overweight and obesity than the general population. Our objective was to examine whether copayment elimination increased use of a weight loss clinic by veterans. We examined clinic use by 44,411 new patients seen in a Veterans Affairs (VA) MOVE! weight management clinic before the copayment elimination and clinic use by 64,398 new patients seen in the year after copayment elimination. We examined clinic use via mixed-effects models for patients who were already exempt from copayment and patients who were newly exempt from copayment. We used 2 outcomes before and after copayment elimination: 1) the ratio of number of clinic visits by new users with the mean number of MOVE! clinic visits by all users, and 2) the number of clinic visits by each new user in the 6 months after their first visit. All models were adjusted for patient and clinic factors. Among newly exempt patients, the clinic-standardized rate of new use increased by 2.2% after the copayment was eliminated but increased 12% among already exempt veterans. This finding was confirmed in adjusted analyses. Analysis of number of clinic visits adjusted for patient and clinic factors also found that exempt and nonexempt veterans had similar numbers of repeat clinic visits. We saw an unexpected larger increase in demand among veterans who receive all VA care for free. These results suggest that VA should not assume that copayment reductions for selective preventive services will motivate patient change and achieve intended system-level outcomes.